Bio-Techne (TECH) Long-Term Investments (2010 - 2026)
Bio-Techne (TECH) posted quarterly Long-Term Investments of $231.0 million for Q1 2026, up 1440.19% year-over-year from $15.0 million in Q1 2025, and down 1.71% quarter-over-quarter from $235.0 million in Q4 2025.
Bio-Techne (TECH) Long-Term Investments (2010 - 2026) Analysis & Trends
Bio-Techne's Long-Term Investments history runs 15 years deep, the most recent figure standing at $231.0 million for Q1 2026.
- In Q1 2026, Long-Term Investments rose 1440.19% year-over-year to $231.0 million; the TTM figure through Mar 2026 stood at $231.0 million (up 1440.19% YoY), while the FY2025 annual figure was $236.0 million, down 2.62% from the prior year.
- Long-Term Investments for Q1 2026 stood at $231.0 million, down from $235.0 million in the prior quarter.
- The five-year high for Long-Term Investments was $255.9 million in Q2 2023, with the low at $15.0 million in Q1 2025.
- The 5-year median for Long-Term Investments is $235.5 million (2025), against an average of $186.8 million.
- The sharpest annual moves came in 2025 and 2026: Long-Term Investments plunged 93.95% in 2025, then soared 1440.19% in 2026.
- Bio-Techne's Long-Term Investments stood at $25.0 million in 2022, then soared by 898.92% to $249.7 million in 2023, then decreased by 3.35% to $241.4 million in 2024, then declined by 2.62% to $235.0 million in 2025, then retreated by 1.71% to $231.0 million in 2026.
- Business Quant data shows TECH's Long-Term Investments at $231.0 million in Q1 2026, $235.0 million in Q4 2025, and $234.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 372.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.17 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn | 231.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 231.03 Mn |
| Dec 31, 2025 | 235.04 Mn |
| Sep 30, 2025 | 234.93 Mn |
| Jun 30, 2025 | 235.98 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Dec 31, 2024 | 241.35 Mn |
| Sep 30, 2024 | 241.31 Mn |
| Jun 30, 2024 | 242.34 Mn |
| Mar 31, 2024 | 247.98 Mn |
| Dec 31, 2023 | 249.73 Mn |
| Sep 30, 2023 | 251.64 Mn |
| Jun 30, 2023 | 255.86 Mn |
| Mar 31, 2023 | 232.00 Mn |
| Dec 31, 2022 | 25.00 Mn |
| Sep 30, 2022 | 25.00 Mn |
| Jun 30, 2022 | 25.00 Mn |
| Dec 31, 2021 | 25.00 Mn |
| Jun 30, 2020 | 6.60 Mn |
| Jun 30, 2018 | 2.61 Mn |
| Mar 31, 2018 | 24.18 Mn |